Innovative Eyewear COO gets grants, sells 9,799 shares

Innovative Eyewear Inc (LUCY) reported insider equity activity by Chief Operating Officer Joaquin Abondano.

Rhea-AI Filing Summary

Innovative Eyewear Inc (LUCY) reported insider equity activity by Chief Operating Officer Joaquin Abondano. On April 2 and August 19, 2026, he received two grants of 14,800 Common Shares each at $0.00 per share as awards. On the same dates, he sold 4,779 shares at $1.0501 per share and 5,020 shares at an average of $0.6765 per share in open-market or private transactions. The August 19 price is disclosed as a weighted average, with detailed trade breakdowns available on request. The filing states these transactions were not conducted under a Rule 10b5-1 trading plan.

Insider Trade Summary

Net Seller: 9,799 shares

Net Sell 4 txns

Insider Abondano Joaquin

Role Chief Operating Officer

Sold 9,799 shs ($8K)

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	14,800	$0.00	$0.00
Sale	Common Stock F1	5,020	$0.6765	$3K
Grant/Award	Common Stock	14,800	$0.00	$0.00
Sale	Common Stock	4,779	$1.0501	$5K

Holdings After Transaction: Common Stock — 25,012 shares (Direct)

Footnotes (1)

1. F1. The price reported in Column 4 is an average price of $0.6765. The Reporting Person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Key Figures

Shares granted: 14,800 shares Shares granted: 14,800 shares Shares sold: 4,779 shares +3 more

6 metrics

Shares granted 14,800 shares Common Stock grant on April 2, 2026 at $0.00 per share

Shares granted 14,800 shares Common Stock grant on August 19, 2026 at $0.00 per share

Shares sold 4,779 shares Common Stock sale on April 2, 2026 at $1.0501 per share

Shares sold 5,020 shares Common Stock sale on August 19, 2026 at average $0.6765 per share

Total shares sold 9,799 shares Aggregate of the two reported Common Stock sales

Rule 10b5-1 checkbox false Filing-level indication that trades are not under a Rule 10b5-1 plan

Key Terms

Grant, award, or other acquisition, Sale in open market or private transaction, weighted average, Reporting Person

4 terms

Grant, award, or other acquisition financial

"transaction code "A" described as "Grant, award, or other acquisition""

Sale in open market or private transaction financial

"transaction code "S" described as "Sale in open market or private transaction""

weighted average financial

"The price reported in Column 4 is an average price of $0.6765"

A weighted average is a way of calculating an overall number when some items matter more than others by giving each item a different level of importance, or weight. Investors use weighted averages to combine figures like prices, returns or earnings so the result reflects the size or significance of each part — like grading a class where a final exam counts more than a quiz, producing a score that better represents true performance.

Reporting Person regulatory

"The Reporting Person undertakes to provide to the registrant"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did LUCY report for Joaquin Abondano on this Form 4?

The Form 4 shows two stock grants of 14,800 shares each to Joaquin Abondano and two sales totaling 9,799 shares of Innovative Eyewear Inc Common Stock in open-market or private transactions.

What prices were the LUCY shares sold for in Abondano’s transactions?

Abondano sold 4,779 LUCY shares at $1.0501 per share on April 2, 2026, and 5,020 shares at an average price of $0.6765 per share on August 19, 2026. The August 19 figure is a weighted average price.

How many LUCY shares did Joaquin Abondano receive as grants?

He received 14,800 Common Shares on April 2, 2026, and another 14,800 Common Shares on August 19, 2026, both recorded at $0.00 per share as grant or award acquisitions.

Were Abondano’s LUCY trades made under a Rule 10b5-1 trading plan?

No. The Form 4 indicates the Rule 10b5-1 checkbox is not affirmed, meaning the reported transactions are not identified as being made pursuant to a Rule 10b5-1 trading plan.

Is detailed price information available for Abondano’s August 19, 2026 LUCY sale?

Yes. The filing notes the $0.6765 per-share figure is a weighted average, and it states that full information on the number of shares sold at each separate price within the range will be provided upon request.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/24/2026 - 04:46 PM EDT Accepted by SEC EDGAR 08/24/2026 - 04:45 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Abondano Joaquin

(Last) (First) (Middle)

C/O INNOVATIVE EYEWEAR INC.

11900 BISCAYNE BLVD., SUITE 630

(Street)

MIAMI FLORIDA 33181

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Innovative Eyewear Inc [ LUCY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Operating Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/02/2026		A		14,800	A	$0.00	20,011	D
Common Stock	04/02/2026		S		4,779	D	$1.0501	15,232	D
Common Stock	08/19/2026		A		14,800	A	$0.00	30,032	D
Common Stock	08/19/2026		S		5,020	D	$0.6765(1)	25,012	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in Column 4 is an average price of $0.6765. The Reporting Person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

	/s/ Joaquin Abondano	08/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)